Patti J. Marks | White & Case LLP International Law Firm, Global Law Practice
Patti Marks
Patti Marks

Patti J. Marks

Counsel, New York

T +1 212 819 7019

E [email protected]

Overview

Patti Marks is a counsel and a member of the M&A Group, the Capital Markets Group and the US Public Company Advisory Group. Her practice includes corporate finance, securities and mergers and acquisitions matters. Ms. Marks has extensive experience representing both issuers and underwriters in public and private debt and equity offerings. Ms. Marks also has extensive experience structuring and advising investment banks and issuers on liability management transactions, focusing on corporate debt restructurings involving issuer buy-backs of outstanding debt securities and consent solicitations. In addition, Ms. Marks regularly advises corporate and investment banking clients in connection with mergers and acquisitions and general corporate and securities laws matters.

Bars and Courts

  • New York State Bar

Education

  • JD, Boston University School of Law
  • BA, Cornell University

Languages

  • English

Experience

ETF Securities Ltd. in the sale of its European commodities exchange traded fund business to Wisdom Tree in a US$611 million cash and stock transaction.

The Walt Disney Company in its offering and sale of C$1.25 billion aggregate principal amount of its 2.875% Notes due 2024.

The Walt Disney Company in its offering and sale of US$500 million 2.125% Notes due 2022 and listed on the Luxembourg Stock Exchange.

The Walt Disney Company with respect to its medium term note and commercial paper programs.

Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a world leader in musculoskeletal health solutions, in its US $13.35 billion deal to acquire Biomet, Inc., one of the world's leading medical device manufacturers.

Macquarie Infrastructure Corporation in its offering and sale of $350 billion aggregate principal amount of its 2.00% Convertible Senior Notes due 2023 in an underwritten public offering.

The underwriters in a US $1.5 billion aggregate principal amount offering of CVS Caremark Corporation's 2.250% Senior Notes due 2019 and 3.375% Senior Notes due 2024.